S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.31 (+2.54%)
MSFT   331.43 (-1.54%)
FB   327.93 (-2.99%)
GOOGL   2,852.99 (-1.98%)
AMZN   3,515.48 (-1.29%)
TSLA   1,131.11 (-0.52%)
NVDA   323.11 (-3.19%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.47 (-5.33%)
AMD   157.50 (-2.72%)
GE   94.86 (-3.60%)
MU   84.91 (-1.43%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.31 (+2.54%)
MSFT   331.43 (-1.54%)
FB   327.93 (-2.99%)
GOOGL   2,852.99 (-1.98%)
AMZN   3,515.48 (-1.29%)
TSLA   1,131.11 (-0.52%)
NVDA   323.11 (-3.19%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.47 (-5.33%)
AMD   157.50 (-2.72%)
GE   94.86 (-3.60%)
MU   84.91 (-1.43%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.31 (+2.54%)
MSFT   331.43 (-1.54%)
FB   327.93 (-2.99%)
GOOGL   2,852.99 (-1.98%)
AMZN   3,515.48 (-1.29%)
TSLA   1,131.11 (-0.52%)
NVDA   323.11 (-3.19%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.47 (-5.33%)
AMD   157.50 (-2.72%)
GE   94.86 (-3.60%)
MU   84.91 (-1.43%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.31 (+2.54%)
MSFT   331.43 (-1.54%)
FB   327.93 (-2.99%)
GOOGL   2,852.99 (-1.98%)
AMZN   3,515.48 (-1.29%)
TSLA   1,131.11 (-0.52%)
NVDA   323.11 (-3.19%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.47 (-5.33%)
AMD   157.50 (-2.72%)
GE   94.86 (-3.60%)
MU   84.91 (-1.43%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
NASDAQ:CNTG

Centogene News Headlines

$6.92
-0.22 (-3.08%)
(As of 11/30/2021 01:09 PM ET)
Add
Compare
Today's Range
$6.82
$7.30
50-Day Range
$6.91
$11.01
52-Week Range
$6.76
$14.00
Volume
894 shs
Average Volume
31,194 shs
Market Capitalization
$137.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-2.11

Media Mentions By Week



Centogene Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CNTG
News Sentiment

0.02

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CNTG Articles
This Week

11

2

CNTG Articles
Average Week

Get Centogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.

Centogene (NASDAQ:CNTG) News Headlines Today

SourceHeadline
MarketBeat logoRobert W. Baird Reaffirms Buy Rating for Centogene (NASDAQ:CNTG)
americanbankingnews.com - November 28 at 6:22 AM
MarketBeat logoCentogene (NASDAQ:CNTG) Releases Earnings Results, Misses Estimates By $0.49 EPS
americanbankingnews.com - November 25 at 11:52 AM
fool.com logoCentogene N.V. (CNTG) Q3 2021 Earnings Call Transcript - Motley Fool
fool.com - November 24 at 8:02 PM
fool.com logoCentogene N.V. (CNTG) Q3 2021 Earnings Call Transcript
fool.com - November 24 at 7:37 PM
finance.yahoo.com logoCentogene N.V. (CNTG) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 24 at 3:01 PM
finance.yahoo.com logoCENTOGENE Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 24 at 10:00 AM
benzinga.com logoEarnings Scheduled For November 24, 2021
benzinga.com - November 24 at 4:47 AM
nasdaq.com logoPre-Market Earnings Report for November 24, 2021 : DE, KC, CD, GOGL, HTHT, CNTG, VIOT, JFIN - Nasdaq
nasdaq.com - November 23 at 6:50 PM
benzinga.com logoEarnings Preview For Centogene - Benzinga
benzinga.com - November 23 at 1:49 PM
seekingalpha.com logoWhat to expect with Twist Bioscience's Q4 performance? - Seeking Alpha
seekingalpha.com - November 19 at 6:00 PM
MarketBeat logoCentogene (CNTG) to Release Quarterly Earnings on Wednesday
americanbankingnews.com - November 19 at 9:58 AM
globenewswire.com logoCENTOGENE to Announce Third Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - November 18 at 10:29 AM
finance.yahoo.com logoCENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021
finance.yahoo.com - November 18 at 10:29 AM
globenewswire.com logoCENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study - GlobeNewswire
globenewswire.com - October 28 at 3:56 PM
finance.yahoo.com logoCancer Biomarkers Market worth 48.20 Billion by 2026 | Market Size, Share, Forecasts, Trends, Research Report with COVID-19 Impact by Fortune Business Insights™ - Yahoo Finance
finance.yahoo.com - October 28 at 9:49 AM
finance.yahoo.com logoCENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
finance.yahoo.com - October 28 at 9:49 AM
nasdaq.com logoWhat You Need To Know About Centogene N.V.'s (NASDAQ:CNTG) Investor Composition - Nasdaq
nasdaq.com - October 21 at 8:13 AM
streetinsider.com logoLibra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer - StreetInsider.com
streetinsider.com - October 19 at 6:21 PM
finance.yahoo.com logoLibra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer - Yahoo Finance
finance.yahoo.com - October 19 at 1:17 PM
finance.yahoo.com logoDo Institutions Own Centogene N.V. (NASDAQ:CNTG) Shares?
finance.yahoo.com - October 19 at 8:16 AM
benzinga.com logoCentogene, Twist Join Forces For Custom Test Kits For Rare Diseases - Benzinga
benzinga.com - October 7 at 2:59 AM
benzinga.com logoCentogene, Twist Bioscience Report Contract To Collab On Development, Commercialization Of Custom Assay Kits For Rare Diseases, No Terms Disclosed - Benzinga
benzinga.com - October 6 at 12:27 PM
finance.yahoo.com logo18 Stocks Moving in Thursday's Pre-Market Session - Yahoo Finance
finance.yahoo.com - September 30 at 12:15 PM
streetinsider.com logoCentogene (CNTG) Family Genetic Research Published in NEJM Reveals Path to Potential Cure for Structural Birth Defects - StreetInsider.com
streetinsider.com - September 29 at 9:13 PM
globenewswire.com logoCENTOGENE's Ground-Breaking Family Genetic Research - GlobeNewswire
globenewswire.com - September 29 at 9:13 PM
finance.yahoo.com logoCENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects
finance.yahoo.com - September 29 at 9:13 PM
nasdaq.com logoNew Strong Sell Stocks for September 10th - Nasdaq
nasdaq.com - September 10 at 1:29 PM
finance.yahoo.com logoCentogene N.V. (CNTG) Q2 2021 Earnings Call Transcript
finance.yahoo.com - September 7 at 8:34 PM
finance.yahoo.com logoCentogene N.V. (CNTG) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - September 7 at 3:32 PM
seekingalpha.com logoCentogene N.V. (CNTG) CEO Andrin Oswald on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - September 7 at 3:32 PM
finance.yahoo.com logoCentogene N.V. (CNTG) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - September 7 at 3:32 PM
seekingalpha.com logoCentogene N.V. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - September 7 at 11:44 AM
globenewswire.com logoCENTOGENE Reports Second Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - September 7 at 6:56 AM
finance.yahoo.com logoCENTOGENE Reports Second Quarter 2021 Financial Results
finance.yahoo.com - September 7 at 6:56 AM
benzinga.com logoEarnings Scheduled For September 7, 2021
benzinga.com - September 7 at 4:24 AM
nasdaq.com logoPre-Market Earnings Report for September 7, 2021 : CNTG - Nasdaq
nasdaq.com - September 3 at 10:38 PM
finance.yahoo.com logoCENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021 - Yahoo Finance
finance.yahoo.com - September 1 at 9:35 AM
nasdaq.com logoValidea Kenneth Fisher Strategy Daily Upgrade Report - 8/28/2021 - Nasdaq
nasdaq.com - August 28 at 8:32 AM
nasdaq.com logoInvestors in Centogene (NASDAQ:CNTG) have unfortunately lost 16% over the last year
nasdaq.com - August 22 at 4:12 PM
finance.yahoo.com logoNovel Drugs are Being Investigated for Gaucher's Disease Treatment: A Clinical Trial Analysis Review by DelveInsight - Yahoo Finance
finance.yahoo.com - August 5 at 11:59 PM
globenewswire.com logoCENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to - GlobeNewswire
globenewswire.com - July 28 at 8:41 AM
streetinsider.com logoForm 6-K Centogene NV For: Jul 26 - StreetInsider.com
streetinsider.com - July 27 at 12:55 PM
finance.yahoo.com logoCENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development - Yahoo Finance
finance.yahoo.com - July 27 at 7:55 AM
finance.yahoo.com logoCENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development
finance.yahoo.com - July 27 at 7:54 AM
finance.yahoo.com logoGlobal Prenatal Testing & Newborn Screening Markets, 2015-2020, 2020-2025F, 2030F - Yahoo Finance
finance.yahoo.com - July 16 at 7:33 AM
streetinsider.com logoForm 144 Centogene NV Filed by: Stoffelen Richard - StreetInsider.com
streetinsider.com - July 12 at 7:30 AM
businesswire.com logoU.S. Non-Invasive Prenatal Testing Market Research and Outlook Report 2021-2028 - ResearchAndMarkets.com - Business Wire
businesswire.com - July 1 at 2:05 PM
globenewswire.com logoCENTOGENE Announces Shareholders Approve All Resolutions at - GlobeNewswire
globenewswire.com - June 25 at 8:10 AM
finance.yahoo.com logoCENTOGENE Announces Shareholders Approve All Resolutions at Annual General Meeting
finance.yahoo.com - June 25 at 8:10 AM
nasdaq.com logoMost Shareholders Will Probably Agree With PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation - Nasdaq
nasdaq.com - June 23 at 3:04 PM
Get Centogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.